Organ-On-Chip Market by Organ Type (Liver, Kidney, Intestine, Lung, Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose - Global Forecast to 2029
The organ-on-chip market is expected to reach USD 631,073 thousand by 2029 from USD 123,285 thousand in 2024, at a CAGR of 38.6% during the forecast period. The key factors driving the growth of the organ-on-chip market include growing awareness towards the development of alternative methods for animal model-based drug testing and increasing funding from government and private institutions for innovating in the organ-on-chip market. Developments in the field of bio fabrication and microfluidics also contribute to the growth of this market.
The organ-on-chip market has been segmented based on organ type, model type, product and service, application, purpose, and end-user.
“By model type, organ-based model segment accounted for the largest share of the organ-on-chip market”
Based on model type, the organ-on-chip market is categorized into organ-based model and disease-based models. In 2023, organ-based model accounted for the largest share of the market owing to factors such as greater accuracy offered by organ-based organ-on-chip models along with the growing ethical concerns regarding the use of animals for drug testing among other factors.
“By organ type, the liver-on-chip segment accounted for the largest share in the organ-on-chip market”
Based on organ type, the organ-on-chip market is segmented into liver, kidney, lung, heart, intestine and other organs. In 2023, the liver-on-chip segment accounted for a largest share of the organ-on-chip market. Growth in this market segment can be attributed to the significance of liver in drug metabolism and focus of pharmaceutical and biotechnology companies on developing new drugs which are tested for human hepatocytic toxicity on liver-on-chip models.
“North America: accounted for the largest share of the organ-on-chip market”
North America accounted for the largest share of the organ-on-chip market. The large share of the North America region can be attributed to increased government and private institution funding and increasing initiatives to grow awareness and promote adoption of this technology as a substitute to animal testing. Besides, the North America region has a well-established healthcare infrastructure which further supports the growth of this market. Also, presence of several market players in the region is another key factor supporting market growth. Some examples of these players include Emulate, Inc. (US), Obatala Sciences (US), SynVivo, Inc. (US), Nortis, Inc. (US) Axosim (US), among others.
“Europe: The second-largest region in the organ-on-chip market.”
The Europe organ-on-chip market is the second largest market for organ-on-chip. This is attributed to one of the major factors including the growing initiatives for advancements of organ-on-chip technologies, increasing use of advanced technologies such as artificial intelligence for drug development and testing. Collaboration and support offered by the government bodies and private institutions also aid in the growth of this market.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the organ-on-chip market. It aims at estimating the size and future growth potential of the market across different segments, such as the organ type, model type, product and service, application, purpose, end user and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the organ-on-chip market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provides insights on the following pointers”
The organ-on-chip market has been segmented based on organ type, model type, product and service, application, purpose, and end-user.
“By model type, organ-based model segment accounted for the largest share of the organ-on-chip market”
Based on model type, the organ-on-chip market is categorized into organ-based model and disease-based models. In 2023, organ-based model accounted for the largest share of the market owing to factors such as greater accuracy offered by organ-based organ-on-chip models along with the growing ethical concerns regarding the use of animals for drug testing among other factors.
“By organ type, the liver-on-chip segment accounted for the largest share in the organ-on-chip market”
Based on organ type, the organ-on-chip market is segmented into liver, kidney, lung, heart, intestine and other organs. In 2023, the liver-on-chip segment accounted for a largest share of the organ-on-chip market. Growth in this market segment can be attributed to the significance of liver in drug metabolism and focus of pharmaceutical and biotechnology companies on developing new drugs which are tested for human hepatocytic toxicity on liver-on-chip models.
“North America: accounted for the largest share of the organ-on-chip market”
North America accounted for the largest share of the organ-on-chip market. The large share of the North America region can be attributed to increased government and private institution funding and increasing initiatives to grow awareness and promote adoption of this technology as a substitute to animal testing. Besides, the North America region has a well-established healthcare infrastructure which further supports the growth of this market. Also, presence of several market players in the region is another key factor supporting market growth. Some examples of these players include Emulate, Inc. (US), Obatala Sciences (US), SynVivo, Inc. (US), Nortis, Inc. (US) Axosim (US), among others.
“Europe: The second-largest region in the organ-on-chip market.”
The Europe organ-on-chip market is the second largest market for organ-on-chip. This is attributed to one of the major factors including the growing initiatives for advancements of organ-on-chip technologies, increasing use of advanced technologies such as artificial intelligence for drug development and testing. Collaboration and support offered by the government bodies and private institutions also aid in the growth of this market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45%, Directors- 30%, and Executives - 25%
- By Country: North America- 40%, Europe- 30%, Asia Pacific- 20%, Latin America- 5%, and Middle East and Africa- 5%
- Emulate, Inc. (US)
- MIMETAS B.V. (Netherlands)
- TissUse GmBH (Germany)
- Insphero (Switzerland)
- CN Bio Innovations Ltd (UK)
- Dynamic42 GmBH (Germany)
- React4Life (Italy)
- Biomimx S.R.L (Italy)
- Netri (France)
- SynVivo, Inc. (US)
- Nortis, Inc. (US)
- Axosim (US)
- Obatala Sciences (US)
- AlveoliX AG (Switzerland)
- Beonchip (Spain)
- Initio Cell (Netherlands)
- Netri SAS (France)
- Hesperos, Inc. (US)
- Lena Biosciences (US)
- RevivoCell (UK)
- Altis Biosystems (US)
- Bi/ond (Netherlands)
- Cherry Biotech (France)
- Fluigent (France)
- Elvesys (France)
This report provides a detailed picture of the organ-on-chip market. It aims at estimating the size and future growth potential of the market across different segments, such as the organ type, model type, product and service, application, purpose, end user and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the organ-on-chip market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.
The report provides insights on the following pointers”
- Analysis of key drivers (development of alternative drug testing methods), opportunities (Development of multi-organ-chips and extended application in cosmetic and food industry), restraint (limited use of technology in preclinical phase) and challenges (low throughput and scalability) influencing the growth of the organ-on-chip market.
- Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the organ-on-chip market.
- Market Development: Comprehensive information about lucrative markets- the report analyses the organ-on-chip market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the organ-on-chip market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies and product and service offerings of leading players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
FIGURE 1 ORGANS-ON-CHIPS MARKET SEGMENTATION
FIGURE 2 REGIONAL SEGMENTATION
1.4.1 YEARS CONSIDERED
1.4.2 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.1 MARKET SIZE ASSESSMENT AT SEGMENTAL LEVEL
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET GROWTH FORECAST
FIGURE 9 CAGR PROJECTIONS: ORGANS-ON-CHIPS MARKET, 2024–2029
FIGURE 10 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGANS-ON-CHIPS MARKET
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 12 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 13 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 14 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 15 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 16 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND)
FIGURE 17 ORGANS-ON-CHIPS MARKET, BY END USER, 2024 VS. 2029 (USD THOUSAND)
FIGURE 18 GEOGRAPHICAL SNAPSHOT: ORGANS-ON-CHIPS MARKET
4 PREMIUM INSIGHTS
4.1 ORGANS-ON-CHIPS MARKET OVERVIEW
FIGURE 19 RISING ADOPTION OF ORGANS-ON-CHIPS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
4.2 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SHARE, BY MODEL TYPE & COUNTRY (2023)
FIGURE 20 ORGAN-BASED MODELS TO DOMINATE NORTH AMERICAN ORGANS-ON-CHIPS MARKET IN 2023
4.3 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND)
FIGURE 21 TOXICOLOGY RESEARCH TO DOMINATE MARKET BY 2029
4.4 ORGANS-ON-CHIPS MARKET SHARE, BY END USER, 2023
FIGURE 22 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5 ORGANS-ON-CHIPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 GERMANY TO REGISTER HIGHEST GROWTH RATE IN ORGANS-ON-CHIPS MARKET FROM 2024 TO 2029
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 ORGANS-ON-CHIPS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for animal-free testing
5.2.1.2 Ethical concerns regarding use of animal models in drug development
5.2.1.3 Growing drug discovery & development initiatives
5.2.1.4 Development of personalized medicines
5.2.1.5 Advancements in microfluidics and bioengineering
5.2.1.6 Increased government and private funding
5.2.1.7 Greater adoption of OOC technology by pharma & biotech companies
5.2.2 RESTRAINTS
5.2.2.1 Limitation of use restricted to preclinical trials
5.2.2.2 Limited scalability and throughput
5.2.3 OPPORTUNITIES
5.2.3.1 Development of human-on-a-chip models
5.2.3.2 Increasing applications in diverse industries
5.2.3.3 Developing hybrid business model providing both products and services
5.2.4 CHALLENGES
5.2.4.1 Lack of standardization
5.2.4.2 Mimicking complex tissues and organs
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR PRODUCT & SERVICE PROVIDERS
5.4 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICE FOR KEY PLAYERS, BY PRODUCT
5.5 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: RESEARCH & DEVELOPMENT PHASE ADDS MAXIMUM VALUE
5.6 ECOSYSTEM ANALYSIS
FIGURE 27 ECOSYSTEM ANALYSIS: ORGANS-ON-CHIPS MARKET
5.7 PATENT ANALYSIS
FIGURE 28 PATENT APPLICATIONS FOR ORGAN-ON-A-CHIP PRODUCTS, JANUARY 2012–DECEMBER 2023
TABLE 6 ORGANS-ON-CHIPS MARKET: INDICATIVE LIST OF PATENTS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 ORGANS-ON-CHIPS MARKET: SUPPLY CHAIN ANALYSIS
TABLE 7 OVERALL SUPPLY CHAIN ECOSYSTEM FOR ORGANS-ON-CHIPS MARKET
5.9 TECHNOLOGY ANALYSIS
5.10 CASE STUDY ANALYSIS
5.10.1 QUEEN MARY UNIVERSITY LONDON (QMUL) COLLABORATED WITH EMULATE TO ESTABLISH QUEEN MARY+EMULATE ORGANS-ON-CHIPS CENTRE
5.11 TRADE ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2024
TABLE 8 ORGANS-ON-CHIPS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY ANALYSIS
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 ORGANS-ON-CHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 DEGREE OF COMPETITION
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PRODUCTS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
6 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE
6.1 INTRODUCTION
TABLE 14 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
6.2 LIVER
6.2.1 INCREASING PRECLINICAL RESEARCH TO EVALUATE HEPATOTOXICITY TO AID MARKET GROWTH
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 16 NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 17 EUROPE: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 18 ASIA PACIFIC: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 19 LATIN AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.3 KIDNEY
6.3.1 USE OF KIDNEY-ON-A-CHIP MODELS FOR DIKI ASSESSMENT TO SUPPORT MARKET GROWTH
TABLE 20 KIDNEY-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 21 NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 22 EUROPE: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 23 ASIA PACIFIC: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 24 LATIN AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.4 INTESTINE
6.4.1 INCREASING RESEARCH ON GASTROINTESTINAL DISEASE TO PROMOTE GROWTH
TABLE 25 INTESTINE-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 26 NORTH AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 27 EUROPE: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 28 ASIA PACIFIC: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 29 LATIN AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.5 LUNG
6.5.1 ENHANCED PARTICLE SCREENING FOR EVALUATING PULMONARY TOXICITY TO SUPPORT ADOPTION
TABLE 30 LUNG-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 31 NORTH AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 32 EUROPE: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 33 ASIA PACIFIC: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 34 LATIN AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.6 HEART
6.6.1 INCREASING ADOPTION IN STUDYING CARDIOVASCULAR DISEASES TO DRIVE MARKET
TABLE 35 HEART-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 36 NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 37 EUROPE: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 38 ASIA PACIFIC: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 39 LATIN AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.7 OTHER ORGANS
TABLE 40 OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 41 NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 42 EUROPE: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 43 ASIA PACIFIC: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 44 LATIN AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
7 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE
7.1 INTRODUCTION
TABLE 45 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
7.2 ORGAN-BASED MODELS
7.2.1 INCREASING RESEARCH TO UNDERSTAND ORGAN PHYSIOLOGY TO SUPPORT MARKET GROWTH
TABLE 46 ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 47 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 48 EUROPE: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 49 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 50 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
7.3 DISEASE-BASED MODELS
7.3.1 GROWING USE OF OOC PLATFORMS FOR DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 51 ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 52 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 53 EUROPE: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 54 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 55 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
8 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE
8.1 INTRODUCTION
TABLE 56 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
8.2 SERVICES
TABLE 57 ORGAN-ON-A-CHIP SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 58 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 59 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 60 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 61 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 62 ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.2.1 CUSTOM SERVICES
8.2.1.1 Growing demand for customized platforms for therapeutics and research to aid growth
TABLE 63 CUSTOM SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 64 NORTH AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 65 EUROPE: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 66 ASIA PACIFIC: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 67 LATIN AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.2.2 STANDARD SERVICES
8.2.2.1 Increasing use of pre-seeded platforms for drug toxicity assessments to support growth
TABLE 68 STANDARD SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 69 NORTH AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 70 EUROPE: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 71 ASIA PACIFIC: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 72 LATIN AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3 PRODUCTS
TABLE 73 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 74 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 75 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 76 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 77 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 78 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.3.1 INSTRUMENTS
8.3.1.1 Increasing adoption of platforms for drug discovery and development to support market growth
TABLE 79 INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 80 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 81 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 82 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 83 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3.2 CONSUMABLES & ACCESSORIES
8.3.2.1 Growing emphasis on using OOC models for research to drive market
TABLE 84 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 85 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 86 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 87 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 88 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3.3 SOFTWARE
8.3.3.1 Increasing integration of AI for data analytics and prediction to support market growth
TABLE 89 SOFTWARE MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 90 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 91 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 92 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 93 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
9 ORGANS-ON-CHIPS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 94 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
9.2 TOXICOLOGY RESEARCH
9.2.1 EFFECTIVE OUTCOMES TO SUPPORT GROWTH
TABLE 95 ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 96 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 97 EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 98 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 99 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.3 DRUG DISCOVERY
9.3.1 INCREASING FOCUS OF PHARMA COMPANIES ON ADOPTING OOC TO SUPPORT GROWTH
TABLE 100 ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 101 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 102 EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 103 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 104 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.4 PHYSIOLOGICAL MODEL DEVELOPMENT
9.4.1 ACCURACY IN STUDYING IN VIVO MECHANISMS TO DRIVE MARKET
TABLE 105 ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 106 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 107 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 108 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 109 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
9.5.1 GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH
TABLE 110 ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 111 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 112 EUROPE: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 113 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 114 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.6 STEM CELL RESEARCH
9.6.1 GROWING FOCUS ON STEM CELL RESEARCH TO SUPPORT GROWTH
TABLE 115 ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 116 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 117 EUROPE: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 118 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 119 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
10 ORGANS-ON-CHIPS MARKET, BY PURPOSE
10.1 INTRODUCTION
TABLE 120 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
10.2 THERAPEUTICS
10.2.1 INCREASING USE OF OOC TECHNOLOGY IN PRECISION MEDICINE AND TARGETED THERAPY RESEARCH TO AID GROWTH
TABLE 121 ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 122 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 123 EUROPE: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 124 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 125 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
10.3 RESEARCH
10.3.1 INCREASING USE OF OOC PLATFORM FOR RESEARCH TO SUPPORT MARKET GROWTH
TABLE 126 ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 127 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 128 EUROPE: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 129 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 130 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
11 ORGANS-ON-CHIPS MARKET, BY END USER
11.1 INTRODUCTION
TABLE 131 ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.2.1 INCREASING COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES AND OOC MANUFACTURERS TO DRIVE MARKET
TABLE 132 ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 133 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 134 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 135 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 136 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.3 COSMETICS INDUSTRY
11.3.1 GROWING EMPHASIS ON ANIMAL-FREE DRUG TESTING TO PROMOTE MARKET GROWTH
TABLE 137 ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 138 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 139 EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, 2022–2029 (USD THOUSAND)
TABLE 140 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 141 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 INCREASING RESEARCH INTO APPLICATIONS OF OOC TECHNOLOGY TO SUPPORT MARKET GROWTH
TABLE 142 ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 143 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 144 EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 145 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 146 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.5 OTHER END USERS
TABLE 147 ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 148 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 149 EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, 2022–2029 (USD THOUSAND)
TABLE 150 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 151 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
12 ORGANS-ON-CHIPS MARKET, BY REGION
12.1 INTRODUCTION
TABLE 152 ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
12.2 NORTH AMERICA
FIGURE 32 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT
TABLE 153 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 154 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 155 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 156 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 157 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 158 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 159 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 160 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 161 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.1 US
12.2.1.1 US to dominate market due to presence of major companies
TABLE 162 US: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 163 US: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 164 US: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 165 US: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 166 US: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 167 US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 168 US: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 169 US: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.2 CANADA
12.2.2.1 Favorable regulatory environment to support market growth
TABLE 170 CANADA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 171 CANADA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 172 CANADA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 173 CANADA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 174 CANADA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 175 CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 176 CANADA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 177 CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.3 NORTH AMERICA: RECESSION IMPACT
12.3 EUROPE
FIGURE 33 EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT
TABLE 178 EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 179 EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 180 EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 181 EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 182 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 183 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 184 EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 185 EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 186 EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.1 GERMANY
12.3.1.1 Favorable government policies to propel market
TABLE 187 GERMANY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 188 GERMANY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 189 GERMANY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 190 GERMANY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 191 GERMANY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 192 GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 193 GERMANY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 194 GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.2 UK
12.3.2.1 Growing R&D expenditure in pharmaceutical industry to boost market
TABLE 195 UK: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 196 UK: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 197 UK: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 198 UK: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 199 UK: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 200 UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 201 UK: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 202 UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.3 FRANCE
12.3.3.1 Growing funding for research projects to drive market
TABLE 203 FRANCE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 204 FRANCE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 205 FRANCE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 206 FRANCE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 207 FRANCE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 208 FRANCE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 209 FRANCE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 210 FRANCE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.4 ITALY
12.3.4.1 Growing research to aid growth
TABLE 211 ITALY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 212 ITALY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 213 ITALY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 214 ITALY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 215 ITALY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 216 ITALY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 217 ITALY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 218 ITALY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.5 SPAIN
12.3.5.1 Growing R&D expenditure to boost market
TABLE 219 SPAIN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 220 SPAIN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 221 SPAIN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 222 SPAIN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 223 SPAIN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 224 SPAIN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 225 SPAIN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 226 SPAIN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.6 REST OF EUROPE
TABLE 227 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 228 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 229 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 230 REST OF EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 231 REST OF EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 232 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 233 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 234 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.7 EUROPE: RECESSION IMPACT
12.4 ASIA PACIFIC
TABLE 235 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 236 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 237 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 238 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 239 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 240 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 241 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 242 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 243 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.1 CHINA
12.4.1.1 Increasing investments in scientific research and technology to drive market
TABLE 244 CHINA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 245 CHINA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 246 CHINA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 247 CHINA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 248 CHINA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 249 CHINA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 250 CHINA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 251 CHINA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.2 JAPAN
12.4.2.1 Growing innovation in drug research to propel market
TABLE 252 JAPAN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 253 JAPAN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 254 JAPAN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 255 JAPAN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 256 JAPAN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 257 JAPAN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 258 JAPAN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 259 JAPAN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.3 INDIA
12.4.3.1 Rising research to create favorable opportunities for market players
TABLE 260 INDIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 261 INDIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 262 INDIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 263 INDIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 264 INDIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 265 INDIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 266 INDIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 267 INDIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.4 AUSTRALIA
12.4.4.1 Increasing drug development initiatives to support market growth
TABLE 268 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 269 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 270 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 271 AUSTRALIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 272 AUSTRALIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 273 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 274 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 275 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.5 SOUTH KOREA
12.4.5.1 Growing pharma sector to drive market
TABLE 276 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 277 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 278 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 279 SOUTH KOREA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 280 SOUTH KOREA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 281 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 282 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 283 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.6 REST OF ASIA PACIFIC
TABLE 284 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 285 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 286 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 287 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 288 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 289 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 290 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 291 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.7 ASIA PACIFIC: RECESSION IMPACT
12.5 LATIN AMERICA
TABLE 292 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 293 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 294 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 295 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 296 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 297 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 298 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 299 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 300 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.1 BRAZIL
12.5.1.1 Ban on animal testing of cosmetics to support market growth
TABLE 301 BRAZIL: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 302 BRAZIL: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 303 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 304 BRAZIL: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 305 BRAZIL: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 306 BRAZIL: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 307 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 308 BRAZIL: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.2 MEXICO
12.5.2.1 Favorable government policies to aid market growth
TABLE 309 MEXICO: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 310 MEXICO: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 311 MEXICO: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 312 MEXICO: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 313 MEXICO: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 314 MEXICO: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 315 MEXICO: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 316 MEXICO: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.3 REST OF LATIN AMERICA
TABLE 317 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 318 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 319 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 320 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 321 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 322 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 323 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 324 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.4 LATIN AMERICA: RECESSION IMPACT
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
TABLE 325 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 326 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 327 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 328 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 329 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 330 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 331 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 332 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES/RIGHT TO WIN
FIGURE 34 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORGANS-ON-CHIPS MARKET
13.3 REVENUE SHARE ANALYSIS
FIGURE 35 REVENUE SHARE ANALYSIS, 2021–2023 (USD THOUSAND)
13.4 MARKET SHARE ANALYSIS
FIGURE 36 MARKET SHARE ANALYSIS, 2023
TABLE 333 DEGREE OF COMPETITION: ORGANS-ON-CHIPS MARKET
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 37 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
13.5.5 COMPANY FOOTPRINT
TABLE 334 PRODUCT & SERVICE FOOTPRINT
TABLE 335 REGIONAL FOOTPRINT
13.6 COMPANY EVALUATION MATRIX: START-UPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
FIGURE 38 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
13.6.5 COMPETITIVE BENCHMARKING
TABLE 336 DETAILED LIST OF KEY START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
TABLE 337 COMPETITIVE BENCHMARKING OF START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
13.7 COMPETITIVE SCENARIO
13.7.1 PRODUCT/SERVICE LAUNCHES
TABLE 338 ORGANS-ON-CHIPS MARKET: PRODUCT/ SERVICE LAUNCHES, 2021–2024
13.7.2 DEALS
TABLE 339 ORGANS-ON-CHIPS MARKET: DEALS, 2021–2024
13.7.3 OTHER KEY DEVELOPMENTS
TABLE 340 ORGANS-ON-CHIPS MARKET: OTHER DEVELOPMENTS, 2021–2024
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 EMULATE, INC.
TABLE 341 EMULATE, INC.: COMPANY OVERVIEW
TABLE 342 EMULATE, INC.: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 343 EMULATE, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.2 MIMETAS B.V.
TABLE 344 MIMETAS B.V.: COMPANY OVERVIEW
TABLE 345 MIMETAS B.V.: DEALS, 2021–2024
TABLE 346 MIMETAS B.V.: OTHER DEVELOPMENTS, 2021–2024
14.1.3 TISSUSE GMBH
TABLE 347 TISSUSE GMBH: COMPANY OVERVIEW
TABLE 348 TISSUSE GMBH: DEALS, 2021–2024
TABLE 349 TISSUSE GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.4 CN BIO INNOVATIONS LTD.
TABLE 350 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW
TABLE 351 CN BIO INNOVATIONS LTD.: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 352 CN BIO INNOVATIONS LTD.: DEALS, 2021–2024
14.1.5 INSPHERO
TABLE 353 INSPHERO: COMPANY OVERVIEW
TABLE 354 INSPHERO: DEALS, 2021–2024
TABLE 355 INSPHERO: OTHER DEVELOPMENTS, 2021–2024
14.1.6 ALVEOLIX AG
TABLE 356 ALVEOLIX AG: COMPANY OVERVIEW
TABLE 357 ALVEOLIX AG: PRODUCT LAUNCHES, 2021–2024
TABLE 358 ALVEOLIX AG: DEALS, 2021–2024
14.1.7 FLUIGENT
TABLE 359 FLUIGENT: COMPANY OVERVIEW
TABLE 360 FLUIGENT: PRODUCT/SERVICE LAUNCHES, 2021–2024
14.1.8 NORTIS, INC.
TABLE 361 NORTIS, INC.: COMPANY OVERVIEW
14.1.9 HESPEROS, INC.
TABLE 362 HESPEROS, INC.: COMPANY OVERVIEW
TABLE 363 HESPEROS, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.10 AXOSIM
TABLE 364 AXOSIM: COMPANY OVERVIEW
TABLE 365 AXOSIM: PRODUCT LAUNCHES, 2021–2024
TABLE 366 AXOSIM: DEALS, 2021–2024
14.1.11 BEONCHIP
TABLE 367 BEONCHIP: COMPANY OVERVIEW
14.1.12 ALTIS BIOSYSTEMS
TABLE 368 ALTIS BIOSYSTEMS: COMPANY OVERVIEW
TABLE 369 ALTIS BIOSYSTEMS: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 370 ALTIS BIOSYSTEMS: DEALS, 2021–2024
14.1.13 SYNVIVO, INC.
TABLE 371 SYNVIVO, INC.: COMPANY OVERVIEW
14.1.14 OBATALA SCIENCES
TABLE 372 OBATALA SCIENCES: COMPANY OVERVIEW
14.1.15 DYNAMIC42 GMBH
TABLE 373 DYNAMIC42 GMBH: COMPANY OVERVIEW
TABLE 374 DYNAMIC42 GMBH: PRODUCT LAUNCHES, 2021–2024
TABLE 375 DYNAMIC42 GMBH: DEALS, 2021–2024
TABLE 376 DYNAMIC42 GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.16 LENA BIOSCIENCES
TABLE 377 LENA BIOSCIENCES: COMPANY OVERVIEW
TABLE 378 LENA BIOSCIENCES: OTHER DEVELOPMENTS, 2021–2024
14.1.17 AIM BIOTECH PTE. LTD.
TABLE 379 AIM BIOTECH PTE. LTD.: COMPANY OVERVIEW
TABLE 380 AIM BIOTECH PTE. LTD.: PRODUCT/SERVICES LAUNCHES, 2021–2024
TABLE 381 AIM BIOTECH PTE. LTD.: DEALS, 2021–2024
14.1.18 REACT4LIFE
TABLE 382 REACT4LIFE: COMPANY OVERVIEW
14.1.19 INITIO CELL
TABLE 383 INITIO CELL: COMPANY OVERVIEW
14.1.20 NETRI SAS
TABLE 384 NETRI SAS: COMPANY OVERVIEW
TABLE 385 NETRI SAS: PRODUCT LAUNCHES, 2021–2024
TABLE 386 NETRI SAS: DEALS, 2021–2024
TABLE 387 NETRI SAS: OTHER DEVELOPMENTS, 2021–2024
14.1.21 REVIVOCELL
TABLE 388 REVIVOCELL: COMPANY OVERVIEW
14.1.22 BI/OND
TABLE 389 BI/OND: COMPANY OVERVIEW
TABLE 390 BI/OND: OTHER DEVELOPMENTS, 2021–2024
14.1.23 BIOMIMX S.R.L.
TABLE 391 BIOMIMX S.R.L.: COMPANY OVERVIEW
14.1.24 CHERRY BIOTECH
TABLE 392 CHERRY BIOTECH: COMPANY OVERVIEW
14.1.25 ELVESYS
TABLE 393 ELVESYS: COMPANY OVERVIEW
14.1.26 JAVELIN BIOTECH
TABLE 394 JAVELIN BIOTECH: COMPANY OVERVIEW
TABLE 395 JAVELIN BIOTECH: DEALS, 2021–2024
14.1.27 KIRKSTALL LTD.
TABLE 396 KIRKSTALL LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
FIGURE 1 ORGANS-ON-CHIPS MARKET SEGMENTATION
FIGURE 2 REGIONAL SEGMENTATION
1.4.1 YEARS CONSIDERED
1.4.2 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.1 MARKET SIZE ASSESSMENT AT SEGMENTAL LEVEL
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET GROWTH FORECAST
FIGURE 9 CAGR PROJECTIONS: ORGANS-ON-CHIPS MARKET, 2024–2029
FIGURE 10 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ORGANS-ON-CHIPS MARKET
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 12 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 13 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 14 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 15 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2024 VS. 2029 (USD THOUSAND)
FIGURE 16 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND)
FIGURE 17 ORGANS-ON-CHIPS MARKET, BY END USER, 2024 VS. 2029 (USD THOUSAND)
FIGURE 18 GEOGRAPHICAL SNAPSHOT: ORGANS-ON-CHIPS MARKET
4 PREMIUM INSIGHTS
4.1 ORGANS-ON-CHIPS MARKET OVERVIEW
FIGURE 19 RISING ADOPTION OF ORGANS-ON-CHIPS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
4.2 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SHARE, BY MODEL TYPE & COUNTRY (2023)
FIGURE 20 ORGAN-BASED MODELS TO DOMINATE NORTH AMERICAN ORGANS-ON-CHIPS MARKET IN 2023
4.3 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2024 VS. 2029 (USD THOUSAND)
FIGURE 21 TOXICOLOGY RESEARCH TO DOMINATE MARKET BY 2029
4.4 ORGANS-ON-CHIPS MARKET SHARE, BY END USER, 2023
FIGURE 22 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5 ORGANS-ON-CHIPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 GERMANY TO REGISTER HIGHEST GROWTH RATE IN ORGANS-ON-CHIPS MARKET FROM 2024 TO 2029
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 ORGANS-ON-CHIPS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for animal-free testing
5.2.1.2 Ethical concerns regarding use of animal models in drug development
5.2.1.3 Growing drug discovery & development initiatives
5.2.1.4 Development of personalized medicines
5.2.1.5 Advancements in microfluidics and bioengineering
5.2.1.6 Increased government and private funding
5.2.1.7 Greater adoption of OOC technology by pharma & biotech companies
5.2.2 RESTRAINTS
5.2.2.1 Limitation of use restricted to preclinical trials
5.2.2.2 Limited scalability and throughput
5.2.3 OPPORTUNITIES
5.2.3.1 Development of human-on-a-chip models
5.2.3.2 Increasing applications in diverse industries
5.2.3.3 Developing hybrid business model providing both products and services
5.2.4 CHALLENGES
5.2.4.1 Lack of standardization
5.2.4.2 Mimicking complex tissues and organs
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR PRODUCT & SERVICE PROVIDERS
5.4 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICE FOR KEY PLAYERS, BY PRODUCT
5.5 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: RESEARCH & DEVELOPMENT PHASE ADDS MAXIMUM VALUE
5.6 ECOSYSTEM ANALYSIS
FIGURE 27 ECOSYSTEM ANALYSIS: ORGANS-ON-CHIPS MARKET
5.7 PATENT ANALYSIS
FIGURE 28 PATENT APPLICATIONS FOR ORGAN-ON-A-CHIP PRODUCTS, JANUARY 2012–DECEMBER 2023
TABLE 6 ORGANS-ON-CHIPS MARKET: INDICATIVE LIST OF PATENTS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 29 ORGANS-ON-CHIPS MARKET: SUPPLY CHAIN ANALYSIS
TABLE 7 OVERALL SUPPLY CHAIN ECOSYSTEM FOR ORGANS-ON-CHIPS MARKET
5.9 TECHNOLOGY ANALYSIS
5.10 CASE STUDY ANALYSIS
5.10.1 QUEEN MARY UNIVERSITY LONDON (QMUL) COLLABORATED WITH EMULATE TO ESTABLISH QUEEN MARY+EMULATE ORGANS-ON-CHIPS CENTRE
5.11 TRADE ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2024
TABLE 8 ORGANS-ON-CHIPS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY ANALYSIS
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 ORGANS-ON-CHIPS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 DEGREE OF COMPETITION
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PRODUCTS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
6 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE
6.1 INTRODUCTION
TABLE 14 ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
6.2 LIVER
6.2.1 INCREASING PRECLINICAL RESEARCH TO EVALUATE HEPATOTOXICITY TO AID MARKET GROWTH
TABLE 15 LIVER-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 16 NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 17 EUROPE: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 18 ASIA PACIFIC: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 19 LATIN AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.3 KIDNEY
6.3.1 USE OF KIDNEY-ON-A-CHIP MODELS FOR DIKI ASSESSMENT TO SUPPORT MARKET GROWTH
TABLE 20 KIDNEY-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 21 NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 22 EUROPE: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 23 ASIA PACIFIC: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 24 LATIN AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.4 INTESTINE
6.4.1 INCREASING RESEARCH ON GASTROINTESTINAL DISEASE TO PROMOTE GROWTH
TABLE 25 INTESTINE-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 26 NORTH AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 27 EUROPE: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 28 ASIA PACIFIC: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 29 LATIN AMERICA: INTESTINE-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.5 LUNG
6.5.1 ENHANCED PARTICLE SCREENING FOR EVALUATING PULMONARY TOXICITY TO SUPPORT ADOPTION
TABLE 30 LUNG-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 31 NORTH AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 32 EUROPE: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 33 ASIA PACIFIC: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 34 LATIN AMERICA: LUNG-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.6 HEART
6.6.1 INCREASING ADOPTION IN STUDYING CARDIOVASCULAR DISEASES TO DRIVE MARKET
TABLE 35 HEART-ON-A-CHIP MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 36 NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 37 EUROPE: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 38 ASIA PACIFIC: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 39 LATIN AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
6.7 OTHER ORGANS
TABLE 40 OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 41 NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 42 EUROPE: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 43 ASIA PACIFIC: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 44 LATIN AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
7 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE
7.1 INTRODUCTION
TABLE 45 ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
7.2 ORGAN-BASED MODELS
7.2.1 INCREASING RESEARCH TO UNDERSTAND ORGAN PHYSIOLOGY TO SUPPORT MARKET GROWTH
TABLE 46 ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 47 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 48 EUROPE: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 49 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 50 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ORGAN-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
7.3 DISEASE-BASED MODELS
7.3.1 GROWING USE OF OOC PLATFORMS FOR DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 51 ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 52 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 53 EUROPE: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 54 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 55 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DISEASE-BASED MODELS, BY COUNTRY, 2022–2029 (USD THOUSAND)
8 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE
8.1 INTRODUCTION
TABLE 56 ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
8.2 SERVICES
TABLE 57 ORGAN-ON-A-CHIP SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 58 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 59 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 60 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 61 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 62 ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.2.1 CUSTOM SERVICES
8.2.1.1 Growing demand for customized platforms for therapeutics and research to aid growth
TABLE 63 CUSTOM SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 64 NORTH AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 65 EUROPE: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 66 ASIA PACIFIC: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 67 LATIN AMERICA: CUSTOM SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.2.2 STANDARD SERVICES
8.2.2.1 Increasing use of pre-seeded platforms for drug toxicity assessments to support growth
TABLE 68 STANDARD SERVICES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 69 NORTH AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 70 EUROPE: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 71 ASIA PACIFIC: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 72 LATIN AMERICA: STANDARD SERVICES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3 PRODUCTS
TABLE 73 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 74 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 75 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 76 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 77 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 78 ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
8.3.1 INSTRUMENTS
8.3.1.1 Increasing adoption of platforms for drug discovery and development to support market growth
TABLE 79 INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 80 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 81 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 82 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 83 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3.2 CONSUMABLES & ACCESSORIES
8.3.2.1 Growing emphasis on using OOC models for research to drive market
TABLE 84 CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 85 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 86 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 87 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 88 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
8.3.3 SOFTWARE
8.3.3.1 Increasing integration of AI for data analytics and prediction to support market growth
TABLE 89 SOFTWARE MARKET, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 90 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 91 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 92 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 93 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
9 ORGANS-ON-CHIPS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 94 ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
9.2 TOXICOLOGY RESEARCH
9.2.1 EFFECTIVE OUTCOMES TO SUPPORT GROWTH
TABLE 95 ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 96 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 97 EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 98 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 99 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.3 DRUG DISCOVERY
9.3.1 INCREASING FOCUS OF PHARMA COMPANIES ON ADOPTING OOC TO SUPPORT GROWTH
TABLE 100 ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 101 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 102 EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 103 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 104 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.4 PHYSIOLOGICAL MODEL DEVELOPMENT
9.4.1 ACCURACY IN STUDYING IN VIVO MECHANISMS TO DRIVE MARKET
TABLE 105 ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 106 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 107 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 108 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 109 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
9.5.1 GROWING RESEARCH INITIATIVES TO SUPPORT MARKET GROWTH
TABLE 110 ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 111 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 112 EUROPE: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 113 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 114 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD THOUSAND)
9.6 STEM CELL RESEARCH
9.6.1 GROWING FOCUS ON STEM CELL RESEARCH TO SUPPORT GROWTH
TABLE 115 ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 116 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 117 EUROPE: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 118 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 119 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
10 ORGANS-ON-CHIPS MARKET, BY PURPOSE
10.1 INTRODUCTION
TABLE 120 ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
10.2 THERAPEUTICS
10.2.1 INCREASING USE OF OOC TECHNOLOGY IN PRECISION MEDICINE AND TARGETED THERAPY RESEARCH TO AID GROWTH
TABLE 121 ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 122 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 123 EUROPE: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 124 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 125 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR THERAPEUTICS, BY COUNTRY, 2022–2029 (USD THOUSAND)
10.3 RESEARCH
10.3.1 INCREASING USE OF OOC PLATFORM FOR RESEARCH TO SUPPORT MARKET GROWTH
TABLE 126 ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 127 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 128 EUROPE: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 129 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 130 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR RESEARCH, BY COUNTRY, 2022–2029 (USD THOUSAND)
11 ORGANS-ON-CHIPS MARKET, BY END USER
11.1 INTRODUCTION
TABLE 131 ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11.2.1 INCREASING COLLABORATION BETWEEN PHARMACEUTICAL COMPANIES AND OOC MANUFACTURERS TO DRIVE MARKET
TABLE 132 ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 133 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 134 EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 135 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 136 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.3 COSMETICS INDUSTRY
11.3.1 GROWING EMPHASIS ON ANIMAL-FREE DRUG TESTING TO PROMOTE MARKET GROWTH
TABLE 137 ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 138 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 139 EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, 2022–2029 (USD THOUSAND)
TABLE 140 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 141 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.4 ACADEMIC & RESEARCH INSTITUTES
11.4.1 INCREASING RESEARCH INTO APPLICATIONS OF OOC TECHNOLOGY TO SUPPORT MARKET GROWTH
TABLE 142 ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 143 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 144 EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 145 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 146 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD THOUSAND)
11.5 OTHER END USERS
TABLE 147 ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD THOUSAND)
TABLE 148 NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 149 EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, 2022–2029 (USD THOUSAND)
TABLE 150 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 151 LATIN AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD THOUSAND)
12 ORGANS-ON-CHIPS MARKET, BY REGION
12.1 INTRODUCTION
TABLE 152 ORGANS-ON-CHIPS MARKET, BY REGION, 2022–2029 (USD THOUSAND)
12.2 NORTH AMERICA
FIGURE 32 NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT
TABLE 153 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 154 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 155 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 156 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 157 NORTH AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 158 NORTH AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 159 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 160 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 161 NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.1 US
12.2.1.1 US to dominate market due to presence of major companies
TABLE 162 US: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 163 US: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 164 US: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 165 US: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 166 US: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 167 US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 168 US: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 169 US: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.2 CANADA
12.2.2.1 Favorable regulatory environment to support market growth
TABLE 170 CANADA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 171 CANADA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 172 CANADA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 173 CANADA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 174 CANADA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 175 CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 176 CANADA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 177 CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.2.3 NORTH AMERICA: RECESSION IMPACT
12.3 EUROPE
FIGURE 33 EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT
TABLE 178 EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 179 EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 180 EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 181 EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 182 EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 183 EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 184 EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 185 EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 186 EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.1 GERMANY
12.3.1.1 Favorable government policies to propel market
TABLE 187 GERMANY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 188 GERMANY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 189 GERMANY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 190 GERMANY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 191 GERMANY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 192 GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 193 GERMANY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 194 GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.2 UK
12.3.2.1 Growing R&D expenditure in pharmaceutical industry to boost market
TABLE 195 UK: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 196 UK: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 197 UK: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 198 UK: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 199 UK: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 200 UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 201 UK: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 202 UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.3 FRANCE
12.3.3.1 Growing funding for research projects to drive market
TABLE 203 FRANCE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 204 FRANCE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 205 FRANCE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 206 FRANCE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 207 FRANCE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 208 FRANCE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 209 FRANCE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 210 FRANCE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.4 ITALY
12.3.4.1 Growing research to aid growth
TABLE 211 ITALY: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 212 ITALY: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 213 ITALY: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 214 ITALY: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 215 ITALY: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 216 ITALY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 217 ITALY: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 218 ITALY: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.5 SPAIN
12.3.5.1 Growing R&D expenditure to boost market
TABLE 219 SPAIN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 220 SPAIN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 221 SPAIN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 222 SPAIN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 223 SPAIN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 224 SPAIN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 225 SPAIN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 226 SPAIN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.6 REST OF EUROPE
TABLE 227 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 228 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 229 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 230 REST OF EUROPE: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 231 REST OF EUROPE: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 232 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 233 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 234 REST OF EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.3.7 EUROPE: RECESSION IMPACT
12.4 ASIA PACIFIC
TABLE 235 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 236 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 237 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 238 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 239 ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 240 ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 241 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 242 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 243 ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.1 CHINA
12.4.1.1 Increasing investments in scientific research and technology to drive market
TABLE 244 CHINA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 245 CHINA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 246 CHINA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 247 CHINA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 248 CHINA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 249 CHINA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 250 CHINA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 251 CHINA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.2 JAPAN
12.4.2.1 Growing innovation in drug research to propel market
TABLE 252 JAPAN: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 253 JAPAN: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 254 JAPAN: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 255 JAPAN: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 256 JAPAN: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 257 JAPAN: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 258 JAPAN: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 259 JAPAN: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.3 INDIA
12.4.3.1 Rising research to create favorable opportunities for market players
TABLE 260 INDIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 261 INDIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 262 INDIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 263 INDIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 264 INDIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 265 INDIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 266 INDIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 267 INDIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.4 AUSTRALIA
12.4.4.1 Increasing drug development initiatives to support market growth
TABLE 268 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 269 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 270 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 271 AUSTRALIA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 272 AUSTRALIA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 273 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 274 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 275 AUSTRALIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.5 SOUTH KOREA
12.4.5.1 Growing pharma sector to drive market
TABLE 276 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 277 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 278 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 279 SOUTH KOREA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 280 SOUTH KOREA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 281 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 282 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 283 SOUTH KOREA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.6 REST OF ASIA PACIFIC
TABLE 284 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 285 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 286 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 287 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 288 REST OF ASIA PACIFIC: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 289 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 290 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 291 REST OF ASIA PACIFIC: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.4.7 ASIA PACIFIC: RECESSION IMPACT
12.5 LATIN AMERICA
TABLE 292 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2022–2029 (USD THOUSAND)
TABLE 293 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 294 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 295 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 296 LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 297 LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 298 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 299 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 300 LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.1 BRAZIL
12.5.1.1 Ban on animal testing of cosmetics to support market growth
TABLE 301 BRAZIL: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 302 BRAZIL: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 303 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 304 BRAZIL: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 305 BRAZIL: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 306 BRAZIL: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 307 BRAZIL: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 308 BRAZIL: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.2 MEXICO
12.5.2.1 Favorable government policies to aid market growth
TABLE 309 MEXICO: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 310 MEXICO: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 311 MEXICO: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 312 MEXICO: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 313 MEXICO: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 314 MEXICO: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 315 MEXICO: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 316 MEXICO: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.3 REST OF LATIN AMERICA
TABLE 317 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 318 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 319 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 320 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 321 REST OF LATIN AMERICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 322 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 323 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 324 REST OF LATIN AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.5.4 LATIN AMERICA: RECESSION IMPACT
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
TABLE 325 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY ORGAN TYPE, 2022–2029 (USD THOUSAND)
TABLE 326 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY MODEL TYPE, 2022–2029 (USD THOUSAND)
TABLE 327 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD THOUSAND)
TABLE 328 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP PRODUCTS MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 329 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP SERVICES MARKET, BY TYPE, 2022–2029 (USD THOUSAND)
TABLE 330 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2022–2029 (USD THOUSAND)
TABLE 331 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY PURPOSE, 2022–2029 (USD THOUSAND)
TABLE 332 MIDDLE EAST & AFRICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2022–2029 (USD THOUSAND)
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY STRATEGIES/RIGHT TO WIN
FIGURE 34 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORGANS-ON-CHIPS MARKET
13.3 REVENUE SHARE ANALYSIS
FIGURE 35 REVENUE SHARE ANALYSIS, 2021–2023 (USD THOUSAND)
13.4 MARKET SHARE ANALYSIS
FIGURE 36 MARKET SHARE ANALYSIS, 2023
TABLE 333 DEGREE OF COMPETITION: ORGANS-ON-CHIPS MARKET
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 37 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
13.5.5 COMPANY FOOTPRINT
TABLE 334 PRODUCT & SERVICE FOOTPRINT
TABLE 335 REGIONAL FOOTPRINT
13.6 COMPANY EVALUATION MATRIX: START-UPS/SMES
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
FIGURE 38 ORGANS-ON-CHIPS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
13.6.5 COMPETITIVE BENCHMARKING
TABLE 336 DETAILED LIST OF KEY START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
TABLE 337 COMPETITIVE BENCHMARKING OF START-UPS/SMES IN ORGANS-ON-CHIPS MARKET
13.7 COMPETITIVE SCENARIO
13.7.1 PRODUCT/SERVICE LAUNCHES
TABLE 338 ORGANS-ON-CHIPS MARKET: PRODUCT/ SERVICE LAUNCHES, 2021–2024
13.7.2 DEALS
TABLE 339 ORGANS-ON-CHIPS MARKET: DEALS, 2021–2024
13.7.3 OTHER KEY DEVELOPMENTS
TABLE 340 ORGANS-ON-CHIPS MARKET: OTHER DEVELOPMENTS, 2021–2024
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 EMULATE, INC.
TABLE 341 EMULATE, INC.: COMPANY OVERVIEW
TABLE 342 EMULATE, INC.: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 343 EMULATE, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.2 MIMETAS B.V.
TABLE 344 MIMETAS B.V.: COMPANY OVERVIEW
TABLE 345 MIMETAS B.V.: DEALS, 2021–2024
TABLE 346 MIMETAS B.V.: OTHER DEVELOPMENTS, 2021–2024
14.1.3 TISSUSE GMBH
TABLE 347 TISSUSE GMBH: COMPANY OVERVIEW
TABLE 348 TISSUSE GMBH: DEALS, 2021–2024
TABLE 349 TISSUSE GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.4 CN BIO INNOVATIONS LTD.
TABLE 350 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW
TABLE 351 CN BIO INNOVATIONS LTD.: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 352 CN BIO INNOVATIONS LTD.: DEALS, 2021–2024
14.1.5 INSPHERO
TABLE 353 INSPHERO: COMPANY OVERVIEW
TABLE 354 INSPHERO: DEALS, 2021–2024
TABLE 355 INSPHERO: OTHER DEVELOPMENTS, 2021–2024
14.1.6 ALVEOLIX AG
TABLE 356 ALVEOLIX AG: COMPANY OVERVIEW
TABLE 357 ALVEOLIX AG: PRODUCT LAUNCHES, 2021–2024
TABLE 358 ALVEOLIX AG: DEALS, 2021–2024
14.1.7 FLUIGENT
TABLE 359 FLUIGENT: COMPANY OVERVIEW
TABLE 360 FLUIGENT: PRODUCT/SERVICE LAUNCHES, 2021–2024
14.1.8 NORTIS, INC.
TABLE 361 NORTIS, INC.: COMPANY OVERVIEW
14.1.9 HESPEROS, INC.
TABLE 362 HESPEROS, INC.: COMPANY OVERVIEW
TABLE 363 HESPEROS, INC.: OTHER DEVELOPMENTS, 2021–2024
14.1.10 AXOSIM
TABLE 364 AXOSIM: COMPANY OVERVIEW
TABLE 365 AXOSIM: PRODUCT LAUNCHES, 2021–2024
TABLE 366 AXOSIM: DEALS, 2021–2024
14.1.11 BEONCHIP
TABLE 367 BEONCHIP: COMPANY OVERVIEW
14.1.12 ALTIS BIOSYSTEMS
TABLE 368 ALTIS BIOSYSTEMS: COMPANY OVERVIEW
TABLE 369 ALTIS BIOSYSTEMS: PRODUCT/SERVICE LAUNCHES, 2021–2024
TABLE 370 ALTIS BIOSYSTEMS: DEALS, 2021–2024
14.1.13 SYNVIVO, INC.
TABLE 371 SYNVIVO, INC.: COMPANY OVERVIEW
14.1.14 OBATALA SCIENCES
TABLE 372 OBATALA SCIENCES: COMPANY OVERVIEW
14.1.15 DYNAMIC42 GMBH
TABLE 373 DYNAMIC42 GMBH: COMPANY OVERVIEW
TABLE 374 DYNAMIC42 GMBH: PRODUCT LAUNCHES, 2021–2024
TABLE 375 DYNAMIC42 GMBH: DEALS, 2021–2024
TABLE 376 DYNAMIC42 GMBH: OTHER DEVELOPMENTS, 2021–2024
14.1.16 LENA BIOSCIENCES
TABLE 377 LENA BIOSCIENCES: COMPANY OVERVIEW
TABLE 378 LENA BIOSCIENCES: OTHER DEVELOPMENTS, 2021–2024
14.1.17 AIM BIOTECH PTE. LTD.
TABLE 379 AIM BIOTECH PTE. LTD.: COMPANY OVERVIEW
TABLE 380 AIM BIOTECH PTE. LTD.: PRODUCT/SERVICES LAUNCHES, 2021–2024
TABLE 381 AIM BIOTECH PTE. LTD.: DEALS, 2021–2024
14.1.18 REACT4LIFE
TABLE 382 REACT4LIFE: COMPANY OVERVIEW
14.1.19 INITIO CELL
TABLE 383 INITIO CELL: COMPANY OVERVIEW
14.1.20 NETRI SAS
TABLE 384 NETRI SAS: COMPANY OVERVIEW
TABLE 385 NETRI SAS: PRODUCT LAUNCHES, 2021–2024
TABLE 386 NETRI SAS: DEALS, 2021–2024
TABLE 387 NETRI SAS: OTHER DEVELOPMENTS, 2021–2024
14.1.21 REVIVOCELL
TABLE 388 REVIVOCELL: COMPANY OVERVIEW
14.1.22 BI/OND
TABLE 389 BI/OND: COMPANY OVERVIEW
TABLE 390 BI/OND: OTHER DEVELOPMENTS, 2021–2024
14.1.23 BIOMIMX S.R.L.
TABLE 391 BIOMIMX S.R.L.: COMPANY OVERVIEW
14.1.24 CHERRY BIOTECH
TABLE 392 CHERRY BIOTECH: COMPANY OVERVIEW
14.1.25 ELVESYS
TABLE 393 ELVESYS: COMPANY OVERVIEW
14.1.26 JAVELIN BIOTECH
TABLE 394 JAVELIN BIOTECH: COMPANY OVERVIEW
TABLE 395 JAVELIN BIOTECH: DEALS, 2021–2024
14.1.27 KIRKSTALL LTD.
TABLE 396 KIRKSTALL LTD.: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
